Literature DB >> 15153476

Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase.

Jonathan A Deane1, Matthew J Trifilo, Claudine M Yballe, Sangdun Choi, Thomas E Lane, David A Fruman.   

Abstract

Phosphoinositide 3-kinase activation is important for lymphocyte proliferation and survival. Disrupting the gene that encodes the major phosphoinositide 3-kinase regulatory isoform p85alpha impairs B cell development and proliferation. However, T cell functions are intact in the absence of p85alpha. In this study, we test the hypothesis that the related isoform p85beta is an essential regulatory subunit for T cell signaling. Unexpectedly, T cells lacking p85beta showed a marked increase in proliferation and decreased death when stimulated with anti-CD3 plus IL-2. Both CD4(+) and CD8(+) T cells completed more cell divisions. Transcriptional profiling revealed reduced levels of caspase-6 mRNA in p85beta-deficient T cells, which was paralleled by reduced caspase-6 enzyme activity. Increased T cell accumulation was also observed in vivo following infection of p85beta-deficient mice with mouse hepatitis virus. Together, these results suggest a unique role for p85beta in limiting T cell expansion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153476     DOI: 10.4049/jimmunol.172.11.6615

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.

Authors:  Vicente Pérez-García; Javier Redondo-Muñoz; Amit Kumar; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

2.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

3.  p85β regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis.

Authors:  Subha Krishnan; Raghuveer Singh Mali; Baskar Ramdas; Emily Sims; Peilin Ma; Joydeep Ghosh; Veerendra Munugalavadla; Philip Hanneman; Joal D Beane; Reuben Kapur
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

4.  Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling.

Authors:  Benjamin G Hale; David Jackson; Yun-Hsiang Chen; Robert A Lamb; Richard E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

5.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

6.  Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.

Authors:  Barbara Geering; Pedro R Cutillas; Gemma Nock; Severine I Gharbi; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

7.  T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase.

Authors:  Anjali J de Souza; Jean S Oak; Ryan Jordanhazy; Rosemarie H DeKruyff; David A Fruman; Lawrence P Kane
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

8.  Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.

Authors:  Veerendra Munugalavadla; Emily C Sims; Jovencio Borneo; Rebecca J Chan; Reuben Kapur
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

9.  MiR-17-92 cluster: an apoptosis inducer or proliferation enhancer.

Authors:  Najmeh Ranji; Majid Sadeghizadeh; Mohammad Ali Shokrgozar; Behnaz Bakhshandeh; Morteza Karimipour; Amir Amanzadeh; Keyhan Azadmanesh
Journal:  Mol Cell Biochem       Date:  2013-05-17       Impact factor: 3.396

Review 10.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.